Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001930337 | SCV002183348 | pathogenic | Pyridoxine-dependent epilepsy | 2021-03-03 | criteria provided, single submitter | clinical testing | This variant has been observed in individual(s) with clinical features of pyridoxine-dependent epilepsy (Invitae). This variant results in the deletion of part of exon 1 (c.184_193-248delinsTGGGGAGCCTG) of the ALDH7A1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ALDH7A1 are known to be pathogenic (PMID: 16491085, 20554659). For these reasons, this variant has been classified as Pathogenic. |